{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:25:04Z","timestamp":1794029104768,"version":"4.8.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006162","name":"FACEPE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.neuropharm.2026.111225","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:53:28Z","timestamp":1791906808000},"page":"111225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Psychoneuroimmunology of glioblastoma: How emotional states shape tumor biology"],"prefix":"10.1016","volume":"302","author":[{"given":"Matheus Vinicius Guimar\u00e3es","family":"de Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaynara Paula Warren","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro C\u00e9sar","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Soares","family":"Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0163-3833","authenticated-orcid":false,"given":"Michelle Melgarejo","family":"da Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuropharm.2026.111225_bib1","first-page":"167","article-title":"Psychological symptoms of illness and emotional distress in advanced cancer cachexia","volume":"25","author":"Amano","year":"2022","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111225_bib2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.molcel.2019.04.017","article-title":"Histone serotonylation: can the brain have \u201chappy\u201d chromatin?","volume":"74","author":"Anastas","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2026.111225_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphyss.2025.100016","article-title":"Changes in adrenoceptor expression level contribute to the cellular plasticity of glioblastoma cells","volume":"75","author":"Asaka","year":"2025","journal-title":"J. Physiol. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111225_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphyss.2025.100016","article-title":"Changes in adrenoceptor expression level contribute to the cellular plasticity of glioblastoma cells","volume":"75","author":"Asaka","year":"2025","journal-title":"J. Physiol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111225_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/brainsci14030275","article-title":"Gene expression of GABAA receptor subunits and association with patient survival in glioma","volume":"14","author":"Badalotti","year":"2024","journal-title":"Brain Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111225_bib6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s13273-024-00433-x","article-title":"Induction of glioblastoma invasion triggered by system Xc- -mediated glutamate release","volume":"20","author":"Baik","year":"2024","journal-title":"Mol. Cell Toxicol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib7","first-page":"1","article-title":"GABAergic neuron-to-glioma synapses in diffuse midline gliomas","author":"Barron","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111225_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/function\/zqad056","article-title":"Striatal dopamine signals and reward learning","volume":"4","author":"Bech","year":"2023","journal-title":"Function"},{"key":"10.1016\/j.neuropharm.2026.111225_bib9","article-title":"Impact of resection location on depressive symptoms following glioma surgery","volume":"7","author":"Belgers","year":"2024","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.neuropharm.2026.111225_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The bidirectional relationship of depression and inflammation: double trouble","volume":"107","author":"Beurel","year":"2020","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111225_bib11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/jnci\/djab018","article-title":"Dopamine receptor antagonists, radiation, and cholesterol biosynthesis in mouse models of glioblastoma","volume":"113","author":"Bhat","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111225_bib12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s43440-024-00644-y","article-title":"Disrupted glutamate homeostasis as a target for glioma therapy","volume":"76","author":"Bieganski","year":"2024","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2026.111225_bib13","article-title":"Cancer as a tool for preclinical psychoneuroimmunology","volume":"18","author":"Borniger","year":"2021","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.neuropharm.2026.111225_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2024.100859","article-title":"Vagus nerve stimulation: novel concept for the treatment of glioblastoma and solid cancers by cytokine (interleukin-6) reduction, attenuating the SASP, enhancing tumor immunity","author":"Brem","year":"2024","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.neuropharm.2026.111225_bib15","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3390\/cells10071783","article-title":"Sex-specific differences in glioblastoma","volume":"10","author":"Carrano","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.111225_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/15347354221096081","article-title":"Biobehavioral pathways and cancer progression: insights for improving well-being and cancer outcomes","volume":"21","author":"Chang","year":"2022","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.neuropharm.2026.111225_bib17","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in Alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2026.111225_bib18","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in Alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2026.111225_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbi.2024.04.019","article-title":"Psychoneuroimmunology in multiple myeloma and autologous hematopoietic stem cell transplant: opportunities for research among patients and caregivers","volume":"119","author":"Christian","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"20","key":"10.1016\/j.neuropharm.2026.111225_bib20","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.3390\/ijms21207777","article-title":"Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer","volume":"21","author":"Colucci-D\u2019Amato","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111225_bib21","first-page":"1","article-title":"Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer","author":"Croft","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.111225_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cytogfr.2021.02.003","article-title":"Latest developments in tryptophan metabolism: understanding its role in B cell immunity","volume":"59","author":"Dagenais-Lussier","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.neuropharm.2026.111225_bib23","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1021\/acschemneuro.2c00170","article-title":"Tolerance and cross-tolerance among psychedelic and nonpsychedelic 5-HT2A receptor agonists in mice","volume":"13","author":"De la Fuente Revenga","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111225_bib24","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3390\/cells10071727","article-title":"M2 muscarinic receptor activation impairs mitotic progression and bipolar mitotic spindle formation in human glioblastoma cell lines","volume":"10","author":"Di Bari","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.111225_bib25","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1017\/S1478951524001111","article-title":"Resilience and spiritual well-being as resources for coping with radiotherapy and surviving in patients with glioblastoma","volume":"23","author":"Dinapoli","year":"2024","journal-title":"Palliat. Support Care"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111225_bib26","doi-asserted-by":"crossref","DOI":"10.2217\/cns-2020-0007","article-title":"Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters","volume":"9","author":"Dono","year":"2020","journal-title":"CNS Oncol."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111225_bib27","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/ejn.15992","article-title":"Pro-inflammatory cytokines IL-1\u03b1, IL-6 and TNF-\u03b1 in major depressive disorder: sex-specific associations with psychological symptoms","volume":"57","author":"Elgellaie","year":"2023","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111225_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.neuropharm.2026.111225_bib29","article-title":"The role of yoga in inflammatory markers","volume":"20","author":"Estevao","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"issue":"13","key":"10.1016\/j.neuropharm.2026.111225_bib30","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.3390\/molecules25133093","article-title":"The GABAB receptor\u2014structure, ligand binding and drug development","volume":"25","author":"Evenseth","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2026.111225_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106067","article-title":"Allopregnanolone suppresses glioblastoma survival through decreasing DPYSL3 and S100A11 expression","volume":"219","author":"Feng","year":"2022","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1098482","article-title":"Roles of STAT3 in the pathogenesis and treatment of glioblastoma","volume":"11","author":"Fu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib148","doi-asserted-by":"crossref","first-page":"20095","DOI":"10.18632\/aging.103593","article-title":"Depressive and anxiety disorders worsen the prognosis of glioblastoma","volume":"12","author":"Fu","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.neuropharm.2026.111225_bib33","article-title":"Immunomodulatory mechanisms driving tumor escape in glioblastoma: the central role of IDO and tryptophan metabolism in local and systemic immunotolerance","volume":"169","author":"Gagliardi","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111225_bib34","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1038\/s41467-023-38899-3","article-title":"Natural killer cells and innate lymphoid cells 1 tune anxiety-like behavior and memory in mice via interferon-\u03b3 and acetylcholine","volume":"14","author":"Garofalo","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111225_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-024-04646-x","article-title":"Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition","volume":"168","author":"Geens","year":"2024","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib36","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.3390\/cancers15245790","article-title":"Therapeutic targeting of glioblastoma and the interactions with its microenvironment","volume":"15","author":"Genoud","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111225_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/curroncol32030152","article-title":"Cognitive decline in glioblastoma (GB) patients with different treatment modalities and insights on untreated cases","volume":"32","author":"Ghadimi","year":"2025","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113141","article-title":"Recent findings leading to the discovery of selective dopamine D4 receptor ligands for the treatment of widespread diseases","volume":"212","author":"Giorgioni","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111225_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/toxins16020080","article-title":"Subtype-selective peptide and protein neurotoxic inhibitors of nicotinic acetylcholine receptors enhance proliferation of patient-derived glioblastoma cell lines","volume":"16","author":"Gondarenko","year":"2024","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.neuropharm.2026.111225_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.neuropharm.2026.111225_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105179","article-title":"Impact of insulin and insulin resistance on brain dopamine signalling and reward processing- an underexplored mechanism in the pathophysiology of depression?","volume":"149","author":"Gruber","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.111225_bib149","author":"Gruber"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111225_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/noajnl\/vdab100","article-title":"Mouse models of glioblastoma for the evaluation of novel therapeutic strategies","volume":"3","author":"Haddad","year":"2021","journal-title":"Neuro-Oncology Advances"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111225_bib43","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.3390\/ijms25116253","article-title":"Regulation of neuronal chloride homeostasis by pro- and mature brain-derived neurotrophic factor (BDNF) via KCC2 cation\u2013chloride cotransporters in rat cortical neurons","volume":"25","author":"Hamze","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111225_bib44","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s11845-020-02374-5","article-title":"Anxiety and depression in glioma patients: prevalence, risk factors, and their correlation with survival","volume":"190","author":"Hao","year":"2021","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.neuropharm.2026.111225_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211163","article-title":"Neural circuit connections and functions of Locus coeruleus\u2013norepinephrine system","volume":"26","author":"Hao","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. C","key":"10.1016\/j.neuropharm.2026.111225_bib46","first-page":"S1","article-title":"Genetic predisposition to depression and inflammation impacts symptom burden and survival in patients with head and neck cancer: a longitudinal study","volume":"331","author":"Henry","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2026.111225_bib47","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s12031-020-01542-7","article-title":"\u03b22-Adrenergic receptor stimulation upregulates Cx43 expression on glioblastoma multiforme and olfactory ensheathing cells","volume":"70","author":"Hosseindoost","year":"2020","journal-title":"J. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111225_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3892\/ijo.2022.5394","article-title":"Glioma-neuronal interactions in tumor progression: mechanism, therapeutic strategies and perspectives","volume":"61","author":"Hua","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib49","article-title":"Prevalence of depression and anxiety in patients with glioma: a systematic review and meta-analysis","volume":"10","author":"Huang","year":"2023","journal-title":"Neuro-Oncol. Pract."},{"key":"10.1016\/j.neuropharm.2026.111225_bib50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/cancers12020433","article-title":"The IL-1 antagonist anakinra attenuates glioblastoma aggressiveness by dampening tumor-associated inflammation","volume":"12","author":"H\u00fcbner","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.neuropharm.2026.111225_bib51","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neubiorev.2020.08.010","article-title":"Effect of immune activation on the kynurenine pathway and depression symptoms\u2013a systematic review and meta-analysis","volume":"118","author":"Hunt","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.111225_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100894","article-title":"Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4\/5","volume":"39","author":"Jeon","year":"2023","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111225_bib53","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111225_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1340386","article-title":"Sex-specific molecular differences in glioblastoma: assessing the clinical significance of genetic variants","volume":"13","author":"Jovanovich","year":"2024","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111225_bib55","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.3390\/ijms25126314","article-title":"Beyond psychotropic: potential repurposing of fluoxetine toward cancer therapy","volume":"25","author":"Kadasah","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111225_bib56","first-page":"1","article-title":"Macrophage\/microglia-derived IL-1\u03b2 induces glioblastoma growth via the STAT3-NF-\u03baB pathway","author":"Kai","year":"2022","journal-title":"Hum. Cell"},{"key":"10.1016\/j.neuropharm.2026.111225_bib57","article-title":"Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: an updated review (from 2022 to 2024)","author":"Kang","year":"2024","journal-title":"Chin. Chem. Lett."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111225_bib58","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.7150\/thno.55986","article-title":"Role of serotonin receptor signaling in cancer cells and anti-tumor immunity","volume":"11","author":"Karmakar","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.neuropharm.2026.111225_bib59","article-title":"Cognitive and emotional resilience seven years after brain tumor resection","volume":"18","author":"Kellar","year":"2026","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111225_bib60","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7150\/jca.104759","article-title":"Elevated serum IL-6 as a negative prognostic biomarker in glioblastoma: integrating bioinformatics and clinical validation","volume":"16","author":"Kim","year":"2025","journal-title":"J. Cancer"},{"key":"10.1016\/j.neuropharm.2026.111225_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.943600","article-title":"Influences on cognitive outcomes in adult patients with gliomas: a systematic review","volume":"12","author":"Kirkman","year":"2022","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111225_bib62","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta\u2010analysis of 82 studies","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neuropharm.2026.111225_bib63","series-title":"Tumors of the Central Nervous System","first-page":"645","article-title":"Assessment of cognitive functioning in glioma patients","author":"Konrath","year":"2023"},{"key":"10.1016\/j.neuropharm.2026.111225_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2026.1774736","article-title":"Impact of corticosteroid administration on glioblastoma progression before and after adjuvant treatments: recent updates on contradictory findings and mechanistic interactions","volume":"16","author":"Kurdi","year":"2026","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpnec.2024.100269","article-title":"Distress and inflammation are independently associated with cancer-related symptom severity","volume":"20","author":"Lacourt","year":"2024","journal-title":"Compr. Psychoneuroendocrinol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib66","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cobeha.2021.09.005","article-title":"Role of C-tactile fibers in pain modulation: animal and human perspectives","volume":"43","author":"Larsson","year":"2022","journal-title":"Curr. Opin. Behav. Sci."},{"key":"10.1016\/j.neuropharm.2026.111225_bib67","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/10998004251318385","article-title":"Cytokines and depressive symptoms among adolescents","volume":"27","author":"Leung","year":"2025","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.neuropharm.2026.111225_bib68","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/brainsci14070687","article-title":"Neuroinflammation in glioblastoma: progress and perspectives","volume":"14","author":"Li","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2026.111225_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111759","article-title":"SERPINB5 promotes colorectal cancer invasion and migration by promoting EMT and angiogenesis via the TNF-\u03b1\/NF-\u03baB pathway","volume":"131","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111225_bib73","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13046-024-03255-w","article-title":"SPP1+ macrophages promote head and neck squamous cell carcinoma progression by secreting TNF-\u03b1 and IL-1\u03b2","volume":"43","author":"Liu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111225_bib71","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/crj.13457","article-title":"Serum tumor necrosis factor \u03b1, interleukin\u20101\u03b2, interleukin-6, and interleukin-17 relate to anxiety and depression risks to some extent in non-small cell lung cancer survivor","volume":"16","author":"Liu","year":"2022","journal-title":"Clin. Res. J"},{"issue":"7882","key":"10.1016\/j.neuropharm.2026.111225_bib69","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41586-021-04001-4","article-title":"A neuroanatomical basis for electroacupuncture to drive the vagal\u2013adrenal axis","volume":"598","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111225_bib72","article-title":"Stress and cancer: the mechanisms of immune dysregulation and management","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib70","article-title":"Stress and cancer: the mechanisms of immune dysregulation and management","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"697","key":"10.1016\/j.neuropharm.2026.111225_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf2281","article-title":"Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell\u2013dependent regression of glioblastoma","volume":"15","author":"Look","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2026.111225_bib76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/nop\/npac067","article-title":"The emotional journey of neuro-oncology: primary brain tumor patients share their experience during this life-threatening disease","volume":"10","author":"Loughan","year":"2023","journal-title":"Neuro-Oncol. Pract."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111225_bib77","first-page":"474","article-title":"TNF inhibitor pomalidomide sensitizes glioblastoma cells to EGFR inhibition","volume":"50","author":"Luo","year":"2020","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2026.111225_bib78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/09727531221109117","article-title":"Psychoneuroimmunology of meditation","volume":"29","author":"Magan","year":"2022","journal-title":"Ann. Neurosci."},{"issue":"7965","key":"10.1016\/j.neuropharm.2026.111225_bib79","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","article-title":"The neuroscience of cancer","volume":"618","author":"Mancusi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111225_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1335387","article-title":"From pain to tumor immunity: influence of peripheral sensory neurons in cancer","volume":"15","author":"Mardelle","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.635472","article-title":"Anticancer properties of the antipsychotic drug chlorpromazine and its synergism with temozolomide in restraining human glioblastoma proliferation in vitro","volume":"11","author":"Matteoni","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111225_bib82","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1021\/acs.jmedchem.4c03150","article-title":"New arylpiperazines as potent and selective dopamine D4 receptor ligands potentially useful to treat glioblastoma","volume":"68","author":"Matteucci","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111225_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.642345","article-title":"Hope and distress are not associated with the brain tumor stage","volume":"12","author":"Mayer","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib84","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jad.2023.03.031","article-title":"DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression","volume":"331","author":"Mendon\u00e7a","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2026.111225_bib85","article-title":"Mental distress and inflammation in bladder cancer: the nerve makes things less vague","volume":"46","author":"Mikolaskova","year":"2025","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.neuropharm.2026.111225_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106745","article-title":"Pathophysiology of nAChRs: limbic circuits and related disorders","volume":"191","author":"Mineur","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2026.111225_bib87","article-title":"Suicidal ideation and attempts in brain tumor patients and survivors: a systematic review","volume":"5","author":"Mofatteh","year":"2023","journal-title":"Neuro-Oncol. Adv."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111225_bib88","first-page":"157","article-title":"Exploring inflammation and stress as biological correlates of symptoms in children with advanced cancer: a longitudinal feasibility study","volume":"41","author":"Montgomery","year":"2024","journal-title":"J. Pediatr. Hematol. Oncol. Nurs."},{"key":"10.1016\/j.neuropharm.2026.111225_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/cbin.70005","article-title":"Role of glutamate excitotoxicity in glioblastoma growth and its implications in treatment","author":"Moriarty","year":"2025","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.neuropharm.2026.111225_bib90","doi-asserted-by":"crossref","first-page":"120","DOI":"10.22551\/2024.45.1104.10302","article-title":"Neuropsychiatric symptoms as early indicators of brain tumors","volume":"11","author":"Moro\u015fan","year":"2024","journal-title":"Arch. Clin. Cases."},{"key":"10.1016\/j.neuropharm.2026.111225_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111227","article-title":"Growth of the prefrontal cortical glioblastoma altered cognitive and emotional behaviors via mediating miRNAs and GABA-A receptor signaling pathways in rats","author":"Nateghi","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.111225_bib92","series-title":"Behavioral Neurobiology of GABAB Receptor Function","first-page":"81","article-title":"GABAB receptor chemistry and pharmacology: agonists, antagonists, and allosteric modulators","author":"Nieto","year":"2021"},{"key":"10.1016\/j.neuropharm.2026.111225_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-026-01192-5","article-title":"GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells","author":"Pathak","year":"2026","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.neuropharm.2026.111225_bib94","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111225_bib95","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.21873\/invivo.13196","article-title":"Pre-treatment emotional distress in patients irradiated for malignant glioma","volume":"37","author":"Rades","year":"2023","journal-title":"In Vivo"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111225_bib96","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3390\/molecules27103194","article-title":"Neuroinflammatory markers: key indicators in the pathology of neurodegenerative diseases","volume":"27","author":"Rauf","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2026.111225_bib97","article-title":"A review and novel theoretical model of how negative emotions influence inflammation: the critical role of emotion regulation","volume":"18","author":"Renna","year":"2021","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.neuropharm.2026.111225_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpnec.2024.100240","article-title":"You can't spell distress without stress: expanding our perspective of the intersection between mental and physical health in cancer survivors","author":"Renna","year":"2024","journal-title":"Compr. Psychoneuroendocrinol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111225_bib99","first-page":"5165","article-title":"Health-related quality of life and distress in elderly vs. younger patients with high-grade glioma\u2014results of a multicenter study","volume":"28","author":"Renovanz","year":"2020","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.neuropharm.2026.111225_bib150","author":"Roll"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111225_bib100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"issue":"7904","key":"10.1016\/j.neuropharm.2026.111225_bib101","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41586-022-04517-3","article-title":"Differential assembly diversifies GABAA receptor structures and signalling","volume":"604","author":"Sente","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111225_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108155","article-title":"Central 5-HT receptors and their function; present and future","volume":"177","author":"Sharp","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111225_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174216","article-title":"Regulatory effects of IL-1\u03b2 in the interaction of GBM and tumor-associated monocyte through VCAM-1 and ICAM-1","volume":"905","author":"Shen","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib104","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ncl.2024.05.012","article-title":"Neuropsychological evaluation for oncology","volume":"42","author":"Sheppard","year":"2024","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neuropharm.2026.111225_bib105","doi-asserted-by":"crossref","DOI":"10.1177\/11786469241312475","article-title":"Preoperative peripheral blood serotonin and kynurenine levels are associated with oncological outcomes in glioblastoma IDH-wt patients","volume":"18","author":"Snider","year":"2025","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2026.111225_bib106","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainresbull.2013.07.003","article-title":"Epigenetics of stress adaptations in the brain","volume":"98","author":"Stankiewicz","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.111225_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1457017","article-title":"Influence of neuropathological diagnosis on psychooncological distress in neurooncological patients: a retrospective cross-sectional analysis","volume":"14","author":"Staub-Bartelt","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib108","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.biopsych.2021.11.023","article-title":"The role of the locus coeruleus in pain and associated stress-related disorders","volume":"91","author":"Su\u00e1rez-Pereira","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111225_bib111","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1186\/s12967-025-06657-2","article-title":"Sympathetic nervous system in tumor progression and metabolic regulation: mechanisms and clinical potential","volume":"23","author":"Sun","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neuropharm.2026.111225_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123067","article-title":"Gamma-aminobutyric acid-mediated neuro-immune interactions in glioblastoma: implications for prognosis and immunotherapy response","volume":"357","author":"Sun","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111225_bib109","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbi.2023.10.010","article-title":"Blood-brain barrier dysfunction mediated by the EZH2-Claudin-5 axis drives stress-induced TNF-\u03b1 infiltration and depression-like behaviors","volume":"115","author":"Sun","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"7986","key":"10.1016\/j.neuropharm.2026.111225_bib112","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","article-title":"Glioma synapses recruit mechanisms of adaptive plasticity","volume":"623","author":"Taylor","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111225_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106764","article-title":"Nicotinic acetylcholine receptors in neurological and psychiatric diseases","volume":"191","author":"Terry","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2026.111225_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116722","article-title":"Proteomic and cytokine profiling of a CRTP8-RXFP1 glioma mouse model","volume":"232","author":"Thanasupawat","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111225_bib115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/17410541.2025.2544352","article-title":"Val66Met polymorphism in the BDNF gene and antidepressant response in depression: an updated meta-analysis","volume":"22","author":"Tiongco","year":"2025","journal-title":"Personal. Med"},{"key":"10.1016\/j.neuropharm.2026.111225_bib116","series-title":"Therapeutic Applications of Dopamine D3 Receptor Function: New Insight After 30 Years of Research","first-page":"133","article-title":"Dopamine D3 receptor, cognition and cognitive dysfunctions in neuropsychiatric disorders: from the bench to the bedside","author":"Torrisi","year":"2022"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111225_bib117","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13030-024-00317-5","article-title":"Serum TNF\u03b1 and IL-17A levels may predict increased depressive symptoms: findings from the Shika Study cohort project in Japan","volume":"18","author":"Tsuboi","year":"2024","journal-title":"Biopsychosoc. Med."},{"key":"10.1016\/j.neuropharm.2026.111225_bib120","article-title":"The effect of duloxetine on mood, quality of life and cognitive functioning in glioblastoma patients","year":"2015","journal-title":"ClinicalTrials.gov Identifier: NCT02443194"},{"key":"10.1016\/j.neuropharm.2026.111225_bib121","article-title":"A clinical trial of a Hemp-derived, high cannabidiol product for anxiety in glioblastoma patients","year":"2023","journal-title":"ClinicalTrials.gov Identifier: NCT05753007"},{"key":"10.1016\/j.neuropharm.2026.111225_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189182","article-title":"Glutaminase 2 as a therapeutic target in glioblastoma","author":"Veeramachaneni","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.neuropharm.2026.111225_bib123","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-026-01711-2","article-title":"Suicide risk in glioblastoma multiforme: a brief review of risk factors, screening, and prevention","author":"Waldvogel","year":"2026","journal-title":"Curr. Psychiatry Rep."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111225_bib125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","article-title":"BDNF signaling in context: from synaptic regulation to psychiatric disorders","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111225_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3020","article-title":"Preoperative symptoms of depression, anxiety, and cognitive impairment in glioma patients: a cerebral perfusion CT study","volume":"13","author":"Wang","year":"2023","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuropharm.2026.111225_bib128","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1039\/D2CP05676C","article-title":"A multiple-step screening protocol to identify norepinephrine and dopamine reuptake inhibitors for depression","volume":"25","author":"Wang","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.neuropharm.2026.111225_bib124","first-page":"4521","article-title":"Psychological distress and related factors in patients with brain tumors","volume":"10","author":"Wang","year":"2021","journal-title":"Ann. Palliat. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111225_bib127","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13046-023-02728-8","article-title":"Chronic stress accelerates glioblastoma progression via DRD2\/ERK\/\u03b2-catenin axis and Dopamine\/ERK\/TH positive feedback loop","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2026.111225_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-021-01163-0","article-title":"TNF\u03b1 secreted by glioma-associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy","volume":"9","author":"Wei","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuropharm.2026.111225_bib130","article-title":"Central nervous system and immune cells interactions in cancer: unveiling new therapeutic avenues","volume":"16","author":"Wen","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111225_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/dev.22492","article-title":"The influence of anterior cingulate GABA+ and glutamate on emotion regulation and reactivity in adolescents and adults","volume":"66","author":"Widegren","year":"2024","journal-title":"Dev. Psychobiol."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111225_bib132","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","article-title":"Cancer neuroscience: state of the field, emerging directions","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.111225_bib133","article-title":"Neuro-immune-tumor axis in gliomas: a review of mechanisms, models, and translational opportunities","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111225_bib134","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13046-024-02947-7","article-title":"The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactions","volume":"43","author":"Xue","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2026.111225_bib135","series-title":"Neuro-Oncology","article-title":"Efficacy of perampanel against glioblastoma cells","author":"Yamamuro","year":"2024"},{"key":"10.1016\/j.neuropharm.2026.111225_bib136","series-title":"Psychoneuroimmunology: Methods and Protocols","first-page":"15","article-title":"Personality and psychoneuroimmunology: a systems biology perspective","author":"Yan","year":"2024"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111225_bib137","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1038\/s41467-021-23832-3","article-title":"Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111225_bib139","first-page":"1219","article-title":"Psychological resilience is related to postoperative adverse events and quality of life in patients with glioma: a retrospective cohort study. Transl","volume":"11","author":"Yang","year":"2022","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111225_bib138","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3892\/or.2021.8025","article-title":"Dopamine receptor D1 agonist inhibits glioblastoma via calpain-mediated ER stress and mitochondrial dysfunction","volume":"45","author":"Yang","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.neuropharm.2026.111225_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114410","article-title":"GABAergic signaling as a potential therapeutic target in cancers","volume":"161","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111225_bib141","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/ijms24010560","article-title":"Allopregnanolone: metabolism, mechanisms of action, and its role in cancer","volume":"24","author":"Zamora-S\u00e1nchez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111225_bib142","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00701-020-04643-9","article-title":"Insular lobe surgery and cognitive impairment in gliomas operated with intraoperative neurophysiological monitoring","volume":"163","author":"Zarino","year":"2021","journal-title":"Acta Neurochir."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111225_bib143","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15622975.2021.1925152","article-title":"Cognition-immune interactions between executive function and working memory, tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR1 and sTNFR2) in bipolar disorder","volume":"23","author":"Zazula","year":"2022","journal-title":"World J. Biol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111225_bib146","doi-asserted-by":"crossref","first-page":"917","DOI":"10.32604\/or.2023.030425","article-title":"CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors","volume":"31","author":"Zhang","year":"2023","journal-title":"Oncol. Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111225_bib144","first-page":"1294","article-title":"Chronic stress-induced immune dysregulation in cancer: implications for initiation, progression, metastasis, and treatment","volume":"10","author":"Zhang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.neuropharm.2026.111225_bib145","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8153","article-title":"Chronic stress promotes glioma cell proliferation via the PI3K\/Akt signaling pathway","volume":"46","author":"Zhang","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.neuropharm.2026.111225_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147280","article-title":"Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition","volume":"1756","author":"Zhong","year":"2021","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826004004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826004004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:52:08Z","timestamp":1794027128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826004004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":148,"alternative-id":["S0028390826004004"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111225","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychoneuroimmunology of glioblastoma: How emotional states shape tumor biology","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111225"}}